hNPC-03

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NamehNPC-03
Drug Alias NamehNPC-03
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Huode Bioengineering Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Huode Bioengineering Company Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A